Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3752272018 | Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3752273011 | Methoxy polyethylene glycol-epoetin beta 833.333 microgram/mL solution for injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Methoxy polyethylene glycol-epoetin beta (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Has precise active ingredient | Methoxy polyethylene glycol-epoetin beta (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Has manufactured dose form | Solution for injection | true | Inferred relationship | Some | ||
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Is a | Epoetin beta only product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Is a | Product containing continuous erythropoietin receptor activator | false | Inferred relationship | Some | ||
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator value | 833.333 | false | Inferred relationship | Some | 1 | |
| Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) | Is a | Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR